At a glance
- Originator GlaxoSmithKline
- Class Antiasthmatics
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 22 Sep 2000 No-Development-Reported for Asthma (Unknown route)